Omkar SpecialityChem

₹6.5 -0.2 | 3.3%

WEBSITE BSE:533317 NSE : OMKAR SPC 18 May, 12:50

Market Cap ₹13 Cr.

Stock P/E -1.3

P/B -

Current Price ₹6.5

Book Value ₹ 0

Face Value 10

52W High ₹12.4

Dividend Yield 0%

52W Low ₹ 5.8

Edit Ratio

Omkar SpecialityChem Research see more...

Overview Inc. Year: 2005Industry: Chemicals

Omkar SpecialityChem Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Omkar SpecialityChem Quarterly Results

#(Fig in Cr.)	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Jun 2022
Net Sales	14	13	5	17	12	11	7	4	6	4
Other Income	0	0	1	0	1	0	0	1	0	0
Total Income	14	13	6	17	13	11	7	5	6	4
Total Expenditure	14	15	5	14	9	11	8	7	6	5
Operating Profit	0	-2	1	3	4	0	-0	-2	0	-1
Interest	1	1	1	2	2	1	1	1	2	2
Depreciation	2	1	1	1	1	1	0	0	0	0
Exceptional Income / Expenses	0	0	0	0	0	4	0	0	0	0
Profit Before Tax	-3	-4	-1	1	1	3	-2	-4	-2	-3
Provision for Tax	1	1	0	0	0	-0	0	0	0	0
Profit After Tax	-4	-5	-1	0	1	3	-2	-4	-2	-3
Adjustments	-0	0	0	0	0	-0	-0	0	-0	-0
Profit After Adjustments	-4	-5	-1	0	1	3	-2	-4	-2	-3
Adjusted Earnings Per Share	-2	-2.6	-0.7	0.1	0.3	1.3	-1.1	-1.7	-0.9	-1.4

Omkar SpecialityChem Profit & Loss

#(Fig in Cr.)	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	TTM
Net Sales	167	202	210	193	300	317	192	43	57	45	21
Other Income	4	6	6	5	9	2	4	3	0	1	1
Total Income	171	207	215	198	309	319	195	46	57	46	22
Total Expenditure	134	165	177	164	255	259	235	45	57	38	26
Operating Profit	37	42	39	34	54	60	-40	1	0	8	-3
Interest	8	7	12	11	17	22	26	15	5	6	6
Depreciation	6	6	6	2	4	11	8	8	7	4	0
Exceptional Income / Expenses	0	0	-0	0	0	-164	-53	10	0	4	0
Profit Before Tax	23	29	21	20	33	-137	-127	-12	-11	3	-11
Provision for Tax	7	8	6	3	11	-27	-23	5	3	1	0
Profit After Tax	16	21	15	18	22	-109	-104	-17	-15	2	-11
Adjustments	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	16	21	15	18	22	-109	-104	-17	-15	2	-11
Adjusted Earnings Per Share	8.4	10.6	7.4	8.7	10.8	-53.1	-50.5	-8.2	-7.1	1	-5.1

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	-21%	-38%	-32%	0%
Operating Profit CAGR	0%	0%	-32%	0%
PAT CAGR	0%	0%	-38%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-7%	-15%	-12%	-25%
ROE Average	0%	0%	-24%	-5%
ROCE Average	12%	2%	-21%	-3%

Omkar SpecialityChem Balance Sheet

#(Fig in Cr.)	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021
Shareholder's Funds	106	127	138	163	181	-3	-125	-148	-162	-158
Minority's Interest	0	0	0	0	0	0	0	0	0	0
Borrowings	5	30	37	42	79	58	76	74	74	67
Other Non-Current Liabilities	2	2	2	4	10	-13	-15	-10	-6	-5
Total Current Liabilities	104	124	164	180	176	251	184	180	185	177
Total Liabilities	217	283	342	389	447	293	120	97	90	80
Fixed Assets	36	44	43	68	78	82	76	68	53	28
Other Non-Current Assets	43	78	122	175	153	19	9	7	7	6
Total Current Assets	138	160	177	145	216	192	35	21	30	46
Total Assets	217	283	342	389	447	293	120	97	90	80

Omkar SpecialityChem Cash Flow

#(Fig in Cr.)	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021
Opening Cash & Cash Equivalents	41	31	22	18	12	1	4	1	0	0
Cash Flow from Operating Activities	-0	0	24	53	-14	107	26	1	4	-16
Cash Flow from Investing Activities	-32	-45	-43	-76	17	-120	-64	11	2	17
Cash Flow from Financing Activities	22	36	15	17	-8	16	35	-14	-5	-1
Net Cash Inflow / Outflow	-10	-9	-4	-6	-5	3	-3	-1	0	-0
Closing Cash & Cash Equivalent	31	22	18	12	7	4	1	0	0	0

Omkar SpecialityChem Ratios

#	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021
Earnings Per Share (Rs)	8.38	10.6	7.44	8.72	10.8	-53.14	-50.52	-8.2	-7.11	0.98
CEPS(Rs)	11.24	13.49	10.55	9.67	12.88	-47.85	-46.56	-4.32	-3.91	2.71
DPS(Rs)	1.25	1.5	1.5	1.5	1.5	0	0	0	0	0
Book NAV/Share(Rs)	53.92	62.77	68.46	79.18	88.17	-1.37	-60.79	-71.96	-78.96	-76.94
Core EBITDA Margin(%)	18.76	16.86	14.62	14.01	14.23	16.61	-21.94	-4.41	-0.42	16.33
EBIT Margin(%)	17.67	16.91	14.43	15.43	15.63	-33.32	-50.81	7.26	-11.22	19.32
Pre Tax Margin(%)	13.1	13.46	9.21	9.9	10.46	-39.65	-64.03	-27.01	-19.89	6.98
PAT Margin (%)	9.29	9.65	6.49	8.68	6.96	-31.7	-52.6	-39.56	-25.73	4.46
Cash Profit Margin (%)	12.47	12.29	9.2	9.64	8.3	-28.54	-48.48	-20.83	-14.15	12.35
ROA(%)	8.45	8.33	4.68	4.91	5.32	-29.57	-50.33	-15.57	-15.68	2.36
ROE(%)	16.61	18.16	11.34	12.06	12.9	-122.44	0	0	0	0
ROCE(%)	19.46	16.99	12.1	10.11	14.14	-42.18	-70.35	3.28	-8.38	12.4
Receivable days	67.76	84.67	118.93	135.4	97.45	95.45	81.72	81.26	42.85	74.4
Inventory Days	85.34	98.45	102.64	103.93	66.6	70.24	69.57	30.91	21.6	20.84
Payable days	74.79	70.11	80.85	99.9	68.93	131.06	119.23	246.58	156.64	192
PER(x)	7.06	10.8	19.76	18.48	16.16	0	0	0	0	11.87
Price/Book(x)	1.1	1.82	2.15	2.03	1.98	-111.43	-0.54	-0.22	-0.03	-0.15
Dividend Yield(%)	2.11	1.31	1.02	0.93	0.86	0	0	0	0	0
EV/Net Sales(x)	0.97	1.59	2.02	2.56	1.79	1.53	1.56	6.14	4.18	5.58
EV/Core EBITDA(x)	4.41	7.63	10.98	14.62	9.94	8.12	-7.53	226.44	1146.9	30.58
Net Sales Growth(%)	56.38	20.71	4.01	-7.78	55.2	5.57	-39.51	-77.74	33.35	-20.66
EBIT Growth(%)	56.46	16.52	-10.87	-1.85	56.48	-330.46	12.65	103.09	-305.9	236.64
PAT Growth(%)	62.19	26.48	-29.8	22.82	23.86	-592.3	4.93	83.77	13.26	113.76
EPS Growth(%)	62.19	26.48	-29.8	17.15	23.86	-592.3	4.93	83.77	13.26	113.76
Debt/Equity(x)	0.74	0.96	1.15	1.08	1.02	-64.17	-1.86	-1.55	-1.44	-1.44
Current Ratio(x)	1.32	1.29	1.08	0.81	1.23	0.76	0.19	0.12	0.16	0.26
Quick Ratio(x)	0.82	0.78	0.69	0.5	0.88	0.48	0.17	0.1	0.14	0.25
Interest Cover(x)	3.86	4.9	2.76	2.79	3.02	-5.27	-3.84	0.21	-1.29	1.57
Total Debt/Mcap(x)	0.67	0.53	0.53	0.53	0.52	0.58	3.45	7.03	48.25	9.55

Omkar SpecialityChem Shareholding Pattern

#	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022
Promoter	27.62	27.62	27.62	27.62	27.62	27.62	17.62	17.62	14.71	14.71
FII	0	0	0	0	0	0	0.01	0	0.06	0.06
DII	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Public	72.38	72.38	72.38	72.38	72.38	72.38	82.36	82.37	85.22	85.22
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022
Promoter	0.57	0.57	0.57	0.57	0.57	0.57	0.36	0.36	0.3	0.3
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	1.49	1.49	1.49	1.49	1.49	1.49	1.69	1.69	1.75	1.75
Others	0	0	0	0	0	0	0	0	0	0
Total	2.06	2.06	2.06	2.06	2.06	2.06	2.06	2.06	2.06	2.06

Pros

Company has reduced debt.
Company is almost debt free.

Cons

Though the company is reporting repeated profits, it is not paying out dividend.
Promoter holding is low: 14.71%.
Company has a low return on equity of 0% over the last 3 years.
Debtor days have increased from 156.64 to 192days.
The company has delivered a poor profit growth of -38% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.